Results 111 to 120 of about 69,560 (333)

Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist

open access: yesJournal of Clinical Medicine, 2020
Autoimmune hemolytic anemia (AIHA) is diagnosed in the presence of anemia, hemolysis, and direct antiglobulin test (DAT) positivity with monospecific antisera. Many confounders of anemia and hemolytic markers should be included in the initial workup (i.e.
B. Fattizzo   +3 more
semanticscholar   +1 more source

Evaluation of the Diagnostic Accuracy of the Quantitative Point‐of‐Care SD Biosensor Standard G6PD Test for Assessment of G6PD Deficiency in Infectious Diseases

open access: yesInternational Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background G6PD deficiency affects about 500 million people worldwide and is prevalent in many malaria‐endemic settings. People with G6PD deficiency are at risk of hemolysis when exposed to certain medications, including 8‐aminoquinoline drugs used to treat Plasmodium vivax malaria.
Flavia Regina Medeiros da Silva   +7 more
wiley   +1 more source

Rheumatoid Arthritis and Autoimmune Hemolytic Anemia as First Manifestation of Rhupus

open access: yesCase Reports in Rheumatology, 2020
“Rhupus” syndrome is a rare condition that describes the coexistence of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), which prevalence among patients with SLE varies from 0.01% to 9.7%.
Alejandra Espinosa-Orantes   +4 more
doaj   +1 more source

Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment.

open access: yesBlood Advances, 2019
The terminology applied to autoimmune hemolytic anemia (AIHA) seems inconsistent. We aimed to evaluate the consistency of definitions used for diagnosis and treatment.
Q. Hill, A. Hill, S. Berentsen
semanticscholar   +1 more source

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia

open access: yesJournal of Clinical Medicine, 2020
Autoimmune hemolytic anemia is a rare condition characterized by destruction of red blood cells with and without involvement of complement. It is associated with significant morbidity and mortality.
I. Murakhovskaya
semanticscholar   +1 more source

Never say never

open access: yes
Journal of Hospital Medicine, EarlyView.
Gurpreet Dhaliwal   +4 more
wiley   +1 more source

Epidemiology and Genetics of Rheumatic Diseases Suggest a Constant Rate of DNA Damage as Underlying Cause

open access: yesImmunology, EarlyView.
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley   +1 more source

New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children

open access: yesHaematologica, 2011
Background Autoimmune hemolytic anemia is a rare condition in children. Little is known about its initial presentation and the subsequent progression of the disease.Design and Methods Since 2004, a national observational study has been aiming to ...
Nathalie Aladjidi   +19 more
doaj   +1 more source

Finding the elusive and causative autoantibody: An atypical case of autoimmune hemolytic anemia [PDF]

open access: yes, 2015
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/111227/1/ccr3203 ...
Clark D. A.   +3 more
core   +1 more source

Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia

open access: yesPharmacology, 2020
Background: Autoimmune hemolytic anemia (AIHA) might be associated with underlying hematological malignancies such as chronic lymphocytic leukemia. However, the association between AIHA and chronic myelogenous leukemia is extremely unusual.
Tahseen Hamamyh, M. Yassin
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy